Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M94,237Revenue $M126,761Net Margin (%)3.7Z-Score4.6
Enterprise Value $M105,898EPS $3.7Operating Margin %6.5F-Score6
P/E(ttm))20.0Cash Flow Per Share $4.1Pre-tax Margin (%)6.1Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %12.8Quick Ratio0.8Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %10.7Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow11.4y-y EBITDA Growth Rate %3.4ROA % (ttm)7.0Higher Current Ratio y-yN
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)12.8Less Shares Outstanding y-yY
Payout Ratio %24.0Shares Outstanding M1,169ROI % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSTom Gayner 2014-06-30 Add0.22%$72.58 - $78.92
($75.58)
$ 81.528%Add 105.21%197,000
CVSJoel Greenblatt 2014-06-30 Add0.05%$72.58 - $78.92
($75.58)
$ 81.528%Add 763.24%65,796
CVSScott Black 2014-06-30 Reduce-0.41%$72.58 - $78.92
($75.58)
$ 81.528%Reduce -29.12%126,558
CVSPRIMECAP Management 2014-03-31 Add0.23%$65.44 - $75.3
($70.6)
$ 81.5216%Add 521.24%3,221,930
CVSTom Gayner 2014-03-31 Buy 0.22%$65.44 - $75.3
($70.6)
$ 81.5216%New holding, 96000 sh.96,000
CVSJoel Greenblatt 2014-03-31 Add$65.44 - $75.3
($70.6)
$ 81.5216%Add 77.75%7,622
CVSWallace Weitz 2014-03-31 Sold Out -0.02%$65.44 - $75.3
($70.6)
$ 81.5216%Sold Out0
CVSVanguard Health Care Fund 2013-12-31 Add0.23%$56.64 - $71.58
($64.24)
$ 81.5227%Add 31.57%4,388,100
CVSPRIMECAP Management 2013-12-31 Add0.01%$56.64 - $71.58
($64.24)
$ 81.5227%Add 39.63%518,630
CVSWallace Weitz 2013-12-31 Reduce-0.41%$56.64 - $71.58
($64.24)
$ 81.5227%Reduce -95.05%10,000
CVSRay Dalio 2013-12-31 Sold Out -0.08%$56.64 - $71.58
($64.24)
$ 81.5227%Sold Out0
CVSJoel Greenblatt 2013-12-31 Reduce-0.07%$56.64 - $71.58
($64.24)
$ 81.5227%Reduce -90.39%4,288
CVSJames Barrow 2013-12-31 Reduce-0.02%$56.64 - $71.58
($64.24)
$ 81.5227%Reduce -36.87%361,095
CVSRay Dalio 2013-09-30 Buy 0.08%$57.28 - $62.17
($59.67)
$ 81.5237%New holding, 175050 sh.175,050
CVSJoel Greenblatt 2013-09-30 Add0.03%$57.28 - $62.17
($59.67)
$ 81.5237%Add 58.84%44,606
CVSPRIMECAP Management 2013-09-30 Add0.03%$57.28 - $62.17
($59.67)
$ 81.5237%Add 1668.71%371,430
CVSVanguard Health Care Fund 2013-06-30 Add0.34%$54.13 - $60.35
($57.94)
$ 81.5241%Add 96.21%3,335,100
CVSScott Black 2013-06-30 Add0.13%$54.13 - $60.35
($57.94)
$ 81.5241%Add 11.41%193,337
CVSWallace Weitz 2013-06-30 Reduce-0.77%$54.13 - $60.35
($57.94)
$ 81.5241%Reduce -63.92%201,200
CVSRay Dalio 2013-06-30 Sold Out -0.17%$54.13 - $60.35
($57.94)
$ 81.5241%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS Joel Greenblatt 2014-06-3065,7960.010.06+763.24%
CVS Tom Gayner 2014-06-30197,0000.020.42+105.21%
CVS James Barrow 2014-06-30348,7950.030.04+18.48%
CVS Vanguard Health Care Fund 2014-06-304,388,1000.380.87
CVS Ruane Cunniff 2014-06-3027,02800.01-0.08%
CVS Mario Gabelli 2014-06-301,563,6420.130.62-0.32%
CVS PRIMECAP Management 2014-06-303,206,0700.270.26-0.49%
CVS Scott Black 2014-06-30126,5580.011.4-29.12%
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sussman AndrewSVP & President, MinuteClinic 2014-09-02Sell9,020$79.452.61view
Joyner J. DavidEVP, Sales & Account Services 2014-08-06Sell123,516$76.17.12view
Boratto Eva CSVP, Cont & Chief Acct Officer 2014-07-21Sell22,107$76.776.19view
Denton David MEVP, CFO 2014-07-01Sell74,989$75.887.43view
Boratto Eva CSVP, Cont & Chief Acct Officer 2014-04-02Sell17,108$74.519.41view
Sussman AndrewSVP & President, MinuteClinic 2014-04-02Sell19,210$74.0210.13view
Brennan Troyen AEVP, Chief Medical Officer 2014-03-31Sell18,867$74.339.67view
Lofberg Per GHEVP and President, Caremark 2014-01-03Sell790,888$70.5415.57view
Denton David MEVP, CFO 2014-01-03Sell14,113$70.515.63view
Joyner J. DavidEVP, Sales & Account Services 2014-01-03Sell220,385$70.4915.65view

Press Releases about CVS :

    Quarterly/Annual Reports about CVS:

    News about CVS:

    Articles On GuruFocus.com
    WalMart Diversifies Into Medi-Care Sep 17 2014 
    These 6 Top Dividend Stocks Starting To Take Off Sep 09 2014 
    Markel CIO Tom Gayner Buys Deere, Unilever, Chubb, Sells Capital One Financial, Chevron, Loews Aug 12 2014 
    Weekly CFO Sells Highlight: Equity Residential, Affiliated Managers Group Inc, CVS Caremark Corp. Aug 10 2014 
    Is Walgreen Set For A Better 2014? Jul 28 2014 
    Realty Income: Another BORING and Solid Quarter for the Monthly Dividend Company Jul 24 2014 
    The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
    Steven Romick's Top Five Stocks Jul 11 2014 
    NEW SITE FEATURE: 10-Year Median Scans May 21 2014 
    Rite Aid Corporation May Be a Buy: More Upside Expected May 20 2014 


    More From Other Websites
    Final Glance: Drugstore companies Sep 19 2014
    Midday Glance: Drugstore companies Sep 19 2014
    Early Glance: Drugstore companies Sep 19 2014
    MinuteClinic Walk-in Medical Clinics Opening in Memphis Sep 19 2014
    CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in... Sep 19 2014
    The Outcome of Scotland's Vote, Fed's Action Sep 18 2014
    Rite Aid Dives On Generic Drug Reimbursement Warning Sep 18 2014
    Gilead Down on Weak Simtuzumab Data and Sovaldi News Sep 18 2014
    Rite Aid cuts profit forecast as medications come off patent Sep 18 2014
    US Drugstores: Bitter pill to swallow Sep 18 2014
    Peabody sinks after Goldman downgrade Sep 18 2014
    Cramer's Mad Dash: Rite Aid guidance horrendous Sep 18 2014
    [video] Cramer's Mad Dash: Rite Aid guidance horrendous Sep 18 2014
    [video] Oracle and Rite Aid Set to Report Earnings, Cramer on Kinder Sep 18 2014
    CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill Sep 17 2014
    Gilead's Sovaldi Usage Fades As Hep-C Patients Await Rivals Sep 17 2014
    CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies Sep 17 2014
    The Zacks Analyst Blog Highlights: Walgreen, CVS Health, Vantiv, Apple and Green Dot Sep 17 2014
    Today's Market Thorns, Roses, and All Time Highs... Sep 16 2014
    Retail Sales Rise: 2 Pharmacy Stocks in Focus Sep 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK